Human pituitary tumours express the bHLH transcription factors NeuroD1 and ASH1

E. Ferretti, D. Di Stefano, F. Zazzeroni, R. Gallo, A. Fratticci, R. Carfagnini, S. Angiulli, A. Santoro, G. Minniti, G. Tamburrano, E. Alesse, G. Cantore, A. Gulino, M. L. Jaffrain-Rea

Research output: Contribution to journalArticle

Abstract

Among the transcription factors involved in pituitary ontogenesis and physiology, basic helix-loop-helix (bHLH) have been poorly studied. Members of bHLH family include NeuroD1 and ASH1, both involved in neuroendocrine differentiation. We evaluated their mRNA expression patterns, by semi-quantitative RT-PCR analysis (sq-RT-PCR) and/or Northern blot, in a series of 33 pituitary adenomas (PA), anterior pituitaries, and pituitary cell lines. Immunohistochemistry for NeuroD1 was also performed in 25 PA. Low levels of NeuroD1 were observed in normal pituitaries and in the somatomammotroph cell lines GH 3/GH 4C 1 contrasting with high levels in corticotroph AtT20 cells. NeuroD1 mRNA was widely expressed in PA (82%), with measurable levels found especially in those derived from Pit-1 independent lineages, i.e. corticotroph (5/5) and clinically non-secreting (CNS) adenomas (9/11). According to sq-RT-PCR analysis, overexpression of NeuroD1 compared to normal pituitaries was frequent. Variable nuclear NeuroD1 immunopositivity was also present in about 70% of studied cases. ASH1 mRNA was widely detected in normal pituitaries, in all tumour cell lines and in most PA (84%), with measurable levels in corticotroph (5/5) and CNS (9/11) adenomas, and in a significant subset of PA derived from Pit-1 dependent lineages (9/16). We conclude that: a) NeuroD1 is differentially expressed in PA and its possible ontogenetic and/or pathogenetic implications in non-corticotroph PA are discussed; b) ASH1 is a neuroendocrine marker whose expression is largely conserved in normal and neoplastic pituitary cells.

Original languageEnglish
Pages (from-to)957-965
Number of pages9
JournalJournal of Endocrinological Investigation
Volume26
Issue number10
Publication statusPublished - Oct 2003

Fingerprint

Basic Helix-Loop-Helix Transcription Factors
Pituitary Neoplasms
Corticotrophs
Adenoma
Messenger RNA
Cell Line
Polymerase Chain Reaction
Tumor Cell Line
Northern Blotting
Transcription Factors
Immunohistochemistry

Keywords

  • ASH1
  • NeuroD1
  • Pathogenesis
  • Pituitary tumours
  • Transcription factors

ASJC Scopus subject areas

  • Endocrinology

Cite this

Ferretti, E., Di Stefano, D., Zazzeroni, F., Gallo, R., Fratticci, A., Carfagnini, R., ... Jaffrain-Rea, M. L. (2003). Human pituitary tumours express the bHLH transcription factors NeuroD1 and ASH1. Journal of Endocrinological Investigation, 26(10), 957-965.

Human pituitary tumours express the bHLH transcription factors NeuroD1 and ASH1. / Ferretti, E.; Di Stefano, D.; Zazzeroni, F.; Gallo, R.; Fratticci, A.; Carfagnini, R.; Angiulli, S.; Santoro, A.; Minniti, G.; Tamburrano, G.; Alesse, E.; Cantore, G.; Gulino, A.; Jaffrain-Rea, M. L.

In: Journal of Endocrinological Investigation, Vol. 26, No. 10, 10.2003, p. 957-965.

Research output: Contribution to journalArticle

Ferretti, E, Di Stefano, D, Zazzeroni, F, Gallo, R, Fratticci, A, Carfagnini, R, Angiulli, S, Santoro, A, Minniti, G, Tamburrano, G, Alesse, E, Cantore, G, Gulino, A & Jaffrain-Rea, ML 2003, 'Human pituitary tumours express the bHLH transcription factors NeuroD1 and ASH1', Journal of Endocrinological Investigation, vol. 26, no. 10, pp. 957-965.
Ferretti E, Di Stefano D, Zazzeroni F, Gallo R, Fratticci A, Carfagnini R et al. Human pituitary tumours express the bHLH transcription factors NeuroD1 and ASH1. Journal of Endocrinological Investigation. 2003 Oct;26(10):957-965.
Ferretti, E. ; Di Stefano, D. ; Zazzeroni, F. ; Gallo, R. ; Fratticci, A. ; Carfagnini, R. ; Angiulli, S. ; Santoro, A. ; Minniti, G. ; Tamburrano, G. ; Alesse, E. ; Cantore, G. ; Gulino, A. ; Jaffrain-Rea, M. L. / Human pituitary tumours express the bHLH transcription factors NeuroD1 and ASH1. In: Journal of Endocrinological Investigation. 2003 ; Vol. 26, No. 10. pp. 957-965.
@article{f8276a47166c45c1af71b211a2249271,
title = "Human pituitary tumours express the bHLH transcription factors NeuroD1 and ASH1",
abstract = "Among the transcription factors involved in pituitary ontogenesis and physiology, basic helix-loop-helix (bHLH) have been poorly studied. Members of bHLH family include NeuroD1 and ASH1, both involved in neuroendocrine differentiation. We evaluated their mRNA expression patterns, by semi-quantitative RT-PCR analysis (sq-RT-PCR) and/or Northern blot, in a series of 33 pituitary adenomas (PA), anterior pituitaries, and pituitary cell lines. Immunohistochemistry for NeuroD1 was also performed in 25 PA. Low levels of NeuroD1 were observed in normal pituitaries and in the somatomammotroph cell lines GH 3/GH 4C 1 contrasting with high levels in corticotroph AtT20 cells. NeuroD1 mRNA was widely expressed in PA (82{\%}), with measurable levels found especially in those derived from Pit-1 independent lineages, i.e. corticotroph (5/5) and clinically non-secreting (CNS) adenomas (9/11). According to sq-RT-PCR analysis, overexpression of NeuroD1 compared to normal pituitaries was frequent. Variable nuclear NeuroD1 immunopositivity was also present in about 70{\%} of studied cases. ASH1 mRNA was widely detected in normal pituitaries, in all tumour cell lines and in most PA (84{\%}), with measurable levels in corticotroph (5/5) and CNS (9/11) adenomas, and in a significant subset of PA derived from Pit-1 dependent lineages (9/16). We conclude that: a) NeuroD1 is differentially expressed in PA and its possible ontogenetic and/or pathogenetic implications in non-corticotroph PA are discussed; b) ASH1 is a neuroendocrine marker whose expression is largely conserved in normal and neoplastic pituitary cells.",
keywords = "ASH1, NeuroD1, Pathogenesis, Pituitary tumours, Transcription factors",
author = "E. Ferretti and {Di Stefano}, D. and F. Zazzeroni and R. Gallo and A. Fratticci and R. Carfagnini and S. Angiulli and A. Santoro and G. Minniti and G. Tamburrano and E. Alesse and G. Cantore and A. Gulino and Jaffrain-Rea, {M. L.}",
year = "2003",
month = "10",
language = "English",
volume = "26",
pages = "957--965",
journal = "Journal of Endocrinological Investigation",
issn = "0391-4097",
publisher = "Springer International Publishing",
number = "10",

}

TY - JOUR

T1 - Human pituitary tumours express the bHLH transcription factors NeuroD1 and ASH1

AU - Ferretti, E.

AU - Di Stefano, D.

AU - Zazzeroni, F.

AU - Gallo, R.

AU - Fratticci, A.

AU - Carfagnini, R.

AU - Angiulli, S.

AU - Santoro, A.

AU - Minniti, G.

AU - Tamburrano, G.

AU - Alesse, E.

AU - Cantore, G.

AU - Gulino, A.

AU - Jaffrain-Rea, M. L.

PY - 2003/10

Y1 - 2003/10

N2 - Among the transcription factors involved in pituitary ontogenesis and physiology, basic helix-loop-helix (bHLH) have been poorly studied. Members of bHLH family include NeuroD1 and ASH1, both involved in neuroendocrine differentiation. We evaluated their mRNA expression patterns, by semi-quantitative RT-PCR analysis (sq-RT-PCR) and/or Northern blot, in a series of 33 pituitary adenomas (PA), anterior pituitaries, and pituitary cell lines. Immunohistochemistry for NeuroD1 was also performed in 25 PA. Low levels of NeuroD1 were observed in normal pituitaries and in the somatomammotroph cell lines GH 3/GH 4C 1 contrasting with high levels in corticotroph AtT20 cells. NeuroD1 mRNA was widely expressed in PA (82%), with measurable levels found especially in those derived from Pit-1 independent lineages, i.e. corticotroph (5/5) and clinically non-secreting (CNS) adenomas (9/11). According to sq-RT-PCR analysis, overexpression of NeuroD1 compared to normal pituitaries was frequent. Variable nuclear NeuroD1 immunopositivity was also present in about 70% of studied cases. ASH1 mRNA was widely detected in normal pituitaries, in all tumour cell lines and in most PA (84%), with measurable levels in corticotroph (5/5) and CNS (9/11) adenomas, and in a significant subset of PA derived from Pit-1 dependent lineages (9/16). We conclude that: a) NeuroD1 is differentially expressed in PA and its possible ontogenetic and/or pathogenetic implications in non-corticotroph PA are discussed; b) ASH1 is a neuroendocrine marker whose expression is largely conserved in normal and neoplastic pituitary cells.

AB - Among the transcription factors involved in pituitary ontogenesis and physiology, basic helix-loop-helix (bHLH) have been poorly studied. Members of bHLH family include NeuroD1 and ASH1, both involved in neuroendocrine differentiation. We evaluated their mRNA expression patterns, by semi-quantitative RT-PCR analysis (sq-RT-PCR) and/or Northern blot, in a series of 33 pituitary adenomas (PA), anterior pituitaries, and pituitary cell lines. Immunohistochemistry for NeuroD1 was also performed in 25 PA. Low levels of NeuroD1 were observed in normal pituitaries and in the somatomammotroph cell lines GH 3/GH 4C 1 contrasting with high levels in corticotroph AtT20 cells. NeuroD1 mRNA was widely expressed in PA (82%), with measurable levels found especially in those derived from Pit-1 independent lineages, i.e. corticotroph (5/5) and clinically non-secreting (CNS) adenomas (9/11). According to sq-RT-PCR analysis, overexpression of NeuroD1 compared to normal pituitaries was frequent. Variable nuclear NeuroD1 immunopositivity was also present in about 70% of studied cases. ASH1 mRNA was widely detected in normal pituitaries, in all tumour cell lines and in most PA (84%), with measurable levels in corticotroph (5/5) and CNS (9/11) adenomas, and in a significant subset of PA derived from Pit-1 dependent lineages (9/16). We conclude that: a) NeuroD1 is differentially expressed in PA and its possible ontogenetic and/or pathogenetic implications in non-corticotroph PA are discussed; b) ASH1 is a neuroendocrine marker whose expression is largely conserved in normal and neoplastic pituitary cells.

KW - ASH1

KW - NeuroD1

KW - Pathogenesis

KW - Pituitary tumours

KW - Transcription factors

UR - http://www.scopus.com/inward/record.url?scp=0347182838&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0347182838&partnerID=8YFLogxK

M3 - Article

C2 - 14759067

AN - SCOPUS:0347182838

VL - 26

SP - 957

EP - 965

JO - Journal of Endocrinological Investigation

JF - Journal of Endocrinological Investigation

SN - 0391-4097

IS - 10

ER -